RU2012120834A - PHARMACEUTICAL COMPOSITIONS FOR STIMULATION OF STEM CELLS - Google Patents
PHARMACEUTICAL COMPOSITIONS FOR STIMULATION OF STEM CELLS Download PDFInfo
- Publication number
- RU2012120834A RU2012120834A RU2012120834/15A RU2012120834A RU2012120834A RU 2012120834 A RU2012120834 A RU 2012120834A RU 2012120834/15 A RU2012120834/15 A RU 2012120834/15A RU 2012120834 A RU2012120834 A RU 2012120834A RU 2012120834 A RU2012120834 A RU 2012120834A
- Authority
- RU
- Russia
- Prior art keywords
- growth factor
- pharmaceutical composition
- fgf
- bmp
- factor
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract 28
- 210000000130 stem cell Anatomy 0.000 title claims abstract 15
- 230000000638 stimulation Effects 0.000 title 1
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 claims abstract 17
- 239000000203 mixture Substances 0.000 claims abstract 14
- 108010025020 Nerve Growth Factor Proteins 0.000 claims abstract 8
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims abstract 7
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims abstract 6
- 239000003102 growth factor Substances 0.000 claims abstract 6
- 239000003795 chemical substances by application Substances 0.000 claims abstract 5
- 239000000126 substance Substances 0.000 claims abstract 5
- LKBSMPFEKIBRGC-UHFFFAOYSA-N 2-[[2-(4-methoxyanilino)-4-pyrimidinyl]amino]ethanol Chemical compound C1=CC(OC)=CC=C1NC1=NC=CC(NCCO)=N1 LKBSMPFEKIBRGC-UHFFFAOYSA-N 0.000 claims abstract 4
- 108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 claims abstract 4
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 claims abstract 4
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 claims abstract 4
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 claims abstract 4
- 108010071942 Colony-Stimulating Factors Proteins 0.000 claims abstract 4
- 102000003951 Erythropoietin Human genes 0.000 claims abstract 4
- 108090000394 Erythropoietin Proteins 0.000 claims abstract 4
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims abstract 4
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims abstract 4
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims abstract 4
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims abstract 4
- 102100039939 Growth/differentiation factor 8 Human genes 0.000 claims abstract 4
- 108010056852 Myostatin Proteins 0.000 claims abstract 4
- 102000007072 Nerve Growth Factors Human genes 0.000 claims abstract 4
- 108010023082 activin A Proteins 0.000 claims abstract 4
- 229940112869 bone morphogenetic protein Drugs 0.000 claims abstract 4
- 229940105423 erythropoietin Drugs 0.000 claims abstract 4
- 229940126864 fibroblast growth factor Drugs 0.000 claims abstract 4
- 210000003714 granulocyte Anatomy 0.000 claims abstract 4
- 229940053128 nerve growth factor Drugs 0.000 claims abstract 4
- 239000002269 analeptic agent Substances 0.000 claims abstract 3
- 108010081589 Becaplermin Proteins 0.000 claims abstract 2
- 108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 claims abstract 2
- 108010049976 Bone Morphogenetic Protein 5 Proteins 0.000 claims abstract 2
- 108010049974 Bone Morphogenetic Protein 6 Proteins 0.000 claims abstract 2
- 102100028728 Bone morphogenetic protein 1 Human genes 0.000 claims abstract 2
- 108090000654 Bone morphogenetic protein 1 Proteins 0.000 claims abstract 2
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 claims abstract 2
- 102100022526 Bone morphogenetic protein 5 Human genes 0.000 claims abstract 2
- 102100022525 Bone morphogenetic protein 6 Human genes 0.000 claims abstract 2
- 102000004127 Cytokines Human genes 0.000 claims abstract 2
- 108090000695 Cytokines Proteins 0.000 claims abstract 2
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 claims abstract 2
- 102000003971 Fibroblast Growth Factor 1 Human genes 0.000 claims abstract 2
- 108050003239 Fibroblast growth factor 12 Proteins 0.000 claims abstract 2
- 102100028417 Fibroblast growth factor 12 Human genes 0.000 claims abstract 2
- 102100035308 Fibroblast growth factor 17 Human genes 0.000 claims abstract 2
- 108050002085 Fibroblast growth factor 20 Proteins 0.000 claims abstract 2
- 102100031361 Fibroblast growth factor 20 Human genes 0.000 claims abstract 2
- 102100028072 Fibroblast growth factor 4 Human genes 0.000 claims abstract 2
- 108090000381 Fibroblast growth factor 4 Proteins 0.000 claims abstract 2
- 108090000380 Fibroblast growth factor 5 Proteins 0.000 claims abstract 2
- 102100028073 Fibroblast growth factor 5 Human genes 0.000 claims abstract 2
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims abstract 2
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims abstract 2
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims abstract 2
- 102000048143 Insulin-Like Growth Factor II Human genes 0.000 claims abstract 2
- 108090001117 Insulin-Like Growth Factor II Proteins 0.000 claims abstract 2
- 241001465754 Metazoa Species 0.000 claims abstract 2
- 101000878182 Mus musculus Fibroblast growth factor 15 Proteins 0.000 claims abstract 2
- 101000712605 Theromyzon tessulatum Theromin Proteins 0.000 claims abstract 2
- 229940122388 Thrombin inhibitor Drugs 0.000 claims abstract 2
- 108090000047 fibroblast growth factor 13 Proteins 0.000 claims abstract 2
- 229940088597 hormone Drugs 0.000 claims abstract 2
- 239000005556 hormone Substances 0.000 claims abstract 2
- 210000002540 macrophage Anatomy 0.000 claims abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract 2
- 108010017843 platelet-derived growth factor A Proteins 0.000 claims abstract 2
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 claims abstract 2
- 230000004936 stimulating effect Effects 0.000 claims abstract 2
- 239000003868 thrombin inhibitor Substances 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims 16
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 claims 15
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 claims 10
- 102100037852 Insulin-like growth factor I Human genes 0.000 claims 10
- 102000019034 Chemokines Human genes 0.000 claims 8
- 108010012236 Chemokines Proteins 0.000 claims 8
- 239000003446 ligand Substances 0.000 claims 8
- 241000124008 Mammalia Species 0.000 claims 7
- 239000000825 pharmaceutical preparation Substances 0.000 claims 7
- 229920000728 polyester Polymers 0.000 claims 6
- -1 protein-3 Proteins 0.000 claims 6
- 239000013543 active substance Substances 0.000 claims 5
- 239000011164 primary particle Substances 0.000 claims 4
- 102000013275 Somatomedins Human genes 0.000 claims 3
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims 3
- 102100039037 Vascular endothelial growth factor A Human genes 0.000 claims 3
- 208000019622 heart disease Diseases 0.000 claims 3
- 238000002347 injection Methods 0.000 claims 3
- 239000007924 injection Substances 0.000 claims 3
- 239000011163 secondary particle Substances 0.000 claims 3
- 102100023995 Beta-nerve growth factor Human genes 0.000 claims 2
- 102100036848 C-C motif chemokine 20 Human genes 0.000 claims 2
- 102100021935 C-C motif chemokine 26 Human genes 0.000 claims 2
- 102100032367 C-C motif chemokine 5 Human genes 0.000 claims 2
- 102100032366 C-C motif chemokine 7 Human genes 0.000 claims 2
- 102100036150 C-X-C motif chemokine 5 Human genes 0.000 claims 2
- 229920001661 Chitosan Polymers 0.000 claims 2
- 229920001634 Copolyester Polymers 0.000 claims 2
- 229920002307 Dextran Polymers 0.000 claims 2
- 101000713099 Homo sapiens C-C motif chemokine 20 Proteins 0.000 claims 2
- 101000947186 Homo sapiens C-X-C motif chemokine 5 Proteins 0.000 claims 2
- 101000595923 Homo sapiens Placenta growth factor Proteins 0.000 claims 2
- 102000004889 Interleukin-6 Human genes 0.000 claims 2
- 108090001005 Interleukin-6 Proteins 0.000 claims 2
- 102100026236 Interleukin-8 Human genes 0.000 claims 2
- 108090001007 Interleukin-8 Proteins 0.000 claims 2
- 102100035194 Placenta growth factor Human genes 0.000 claims 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims 2
- 108010010469 Qa-SNARE Proteins Proteins 0.000 claims 2
- 102000036693 Thrombopoietin Human genes 0.000 claims 2
- 108010041111 Thrombopoietin Proteins 0.000 claims 2
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 claims 2
- 102400001320 Transforming growth factor alpha Human genes 0.000 claims 2
- 101800004564 Transforming growth factor alpha Proteins 0.000 claims 2
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 claims 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 2
- 229920000615 alginic acid Polymers 0.000 claims 2
- 235000010443 alginic acid Nutrition 0.000 claims 2
- 229920002678 cellulose Polymers 0.000 claims 2
- 239000001913 cellulose Substances 0.000 claims 2
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 claims 2
- 229960002986 dinoprostone Drugs 0.000 claims 2
- 229940100601 interleukin-6 Drugs 0.000 claims 2
- 239000002502 liposome Substances 0.000 claims 2
- 239000004005 microsphere Substances 0.000 claims 2
- 239000002077 nanosphere Substances 0.000 claims 2
- 239000003900 neurotrophic factor Substances 0.000 claims 2
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims 2
- 229920001610 polycaprolactone Polymers 0.000 claims 2
- 239000004632 polycaprolactone Substances 0.000 claims 2
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 claims 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 claims 2
- NMWKYTGJWUAZPZ-WWHBDHEGSA-N (4S)-4-[[(4R,7S,10S,16S,19S,25S,28S,31R)-31-[[(2S)-2-[[(1R,6R,9S,12S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,53S,56S,59S,62S,65S,68S,71S,76S,79S,85S)-47-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]-18-(4-aminobutyl)-27,68-bis(3-amino-3-oxopropyl)-36,71,76-tribenzyl-39-(3-carbamimidamidopropyl)-24-(2-carboxyethyl)-21,56-bis(carboxymethyl)-65,85-bis[(1R)-1-hydroxyethyl]-59-(hydroxymethyl)-62,79-bis(1H-imidazol-4-ylmethyl)-9-methyl-33-(2-methylpropyl)-8,11,17,20,23,26,29,32,35,38,41,48,54,57,60,63,66,69,72,74,77,80,83,86-tetracosaoxo-30-propan-2-yl-3,4,44,45-tetrathia-7,10,16,19,22,25,28,31,34,37,40,49,55,58,61,64,67,70,73,75,78,81,84,87-tetracosazatetracyclo[40.31.14.012,16.049,53]heptaoctacontane-6-carbonyl]amino]-3-methylbutanoyl]amino]-7-(3-carbamimidamidopropyl)-25-(hydroxymethyl)-19-[(4-hydroxyphenyl)methyl]-28-(1H-imidazol-4-ylmethyl)-10-methyl-6,9,12,15,18,21,24,27,30-nonaoxo-16-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23,26,29-nonazacyclodotriacontane-4-carbonyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[(2S)-1-[[(1S)-1-carboxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid Chemical compound CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](Cc4ccccc4)NC3=O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N3CCC[C@H]3C(=O)N[C@@H](C)C(=O)N2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1)C(=O)N[C@@H](C)C(O)=O NMWKYTGJWUAZPZ-WWHBDHEGSA-N 0.000 claims 1
- 102000015693 Actin Depolymerizing Factors Human genes 0.000 claims 1
- 108010038798 Actin Depolymerizing Factors Proteins 0.000 claims 1
- 102000009840 Angiopoietins Human genes 0.000 claims 1
- 108010009906 Angiopoietins Proteins 0.000 claims 1
- 102400000345 Angiotensin-2 Human genes 0.000 claims 1
- 101800000733 Angiotensin-2 Proteins 0.000 claims 1
- 101710155834 C-C motif chemokine 7 Proteins 0.000 claims 1
- 102100025248 C-X-C motif chemokine 10 Human genes 0.000 claims 1
- 102100025279 C-X-C motif chemokine 11 Human genes 0.000 claims 1
- 102100039398 C-X-C motif chemokine 2 Human genes 0.000 claims 1
- 101710167766 C-type lectin domain family 11 member A Proteins 0.000 claims 1
- 102100032528 C-type lectin domain family 11 member A Human genes 0.000 claims 1
- 102100025597 Caspase-4 Human genes 0.000 claims 1
- 101710090338 Caspase-4 Proteins 0.000 claims 1
- 108010075016 Ceruloplasmin Proteins 0.000 claims 1
- 102100023321 Ceruloplasmin Human genes 0.000 claims 1
- 108010083698 Chemokine CCL26 Proteins 0.000 claims 1
- 108010055166 Chemokine CCL5 Proteins 0.000 claims 1
- 102000016917 Complement C1 Human genes 0.000 claims 1
- 108010028774 Complement C1 Proteins 0.000 claims 1
- 108010028780 Complement C3 Proteins 0.000 claims 1
- 102000016918 Complement C3 Human genes 0.000 claims 1
- 102000012192 Cystatin C Human genes 0.000 claims 1
- 108010061642 Cystatin C Proteins 0.000 claims 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims 1
- 102100020715 Fms-related tyrosine kinase 3 ligand protein Human genes 0.000 claims 1
- 101710162577 Fms-related tyrosine kinase 3 ligand protein Proteins 0.000 claims 1
- 102100034221 Growth-regulated alpha protein Human genes 0.000 claims 1
- 102000014702 Haptoglobin Human genes 0.000 claims 1
- 108050005077 Haptoglobin Proteins 0.000 claims 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 1
- 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 claims 1
- 101000797762 Homo sapiens C-C motif chemokine 5 Proteins 0.000 claims 1
- 101000797758 Homo sapiens C-C motif chemokine 7 Proteins 0.000 claims 1
- 101000858060 Homo sapiens C-X-C motif chemokine 11 Proteins 0.000 claims 1
- 101000889128 Homo sapiens C-X-C motif chemokine 2 Proteins 0.000 claims 1
- 101001069921 Homo sapiens Growth-regulated alpha protein Proteins 0.000 claims 1
- 101001055222 Homo sapiens Interleukin-8 Proteins 0.000 claims 1
- 101100273566 Humulus lupulus CCL10 gene Proteins 0.000 claims 1
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 claims 1
- 101000668058 Infectious salmon anemia virus (isolate Atlantic salmon/Norway/810/9/99) RNA-directed RNA polymerase catalytic subunit Proteins 0.000 claims 1
- 108010041100 Integrin alpha6 Proteins 0.000 claims 1
- 102000000426 Integrin alpha6 Human genes 0.000 claims 1
- 102000004890 Interleukin-8 Human genes 0.000 claims 1
- 102000004856 Lectins Human genes 0.000 claims 1
- 108090001090 Lectins Proteins 0.000 claims 1
- 102000003960 Ligases Human genes 0.000 claims 1
- 108090000364 Ligases Proteins 0.000 claims 1
- 102000004882 Lipase Human genes 0.000 claims 1
- 108090001060 Lipase Proteins 0.000 claims 1
- 102000009073 Macrophage Migration-Inhibitory Factors Human genes 0.000 claims 1
- 108010048043 Macrophage Migration-Inhibitory Factors Proteins 0.000 claims 1
- 102100029268 Neurotrophin-3 Human genes 0.000 claims 1
- 108700023477 Nucleoside diphosphate kinases Proteins 0.000 claims 1
- 235000008753 Papaver somniferum Nutrition 0.000 claims 1
- 240000001090 Papaver somniferum Species 0.000 claims 1
- 102100027913 Peptidyl-prolyl cis-trans isomerase FKBP1A Human genes 0.000 claims 1
- 102100037765 Periostin Human genes 0.000 claims 1
- 101710199268 Periostin Proteins 0.000 claims 1
- 102000011195 Profilin Human genes 0.000 claims 1
- 108050001408 Profilin Proteins 0.000 claims 1
- 239000005700 Putrescine Substances 0.000 claims 1
- 102000015799 Qa-SNARE Proteins Human genes 0.000 claims 1
- 102100030511 Stanniocalcin-1 Human genes 0.000 claims 1
- 101710142157 Stanniocalcin-1 Proteins 0.000 claims 1
- 102100021669 Stromal cell-derived factor 1 Human genes 0.000 claims 1
- 101710088580 Stromal cell-derived factor 1 Proteins 0.000 claims 1
- 102000050707 Syntaxin-11 Human genes 0.000 claims 1
- 108010006877 Tacrolimus Binding Protein 1A Proteins 0.000 claims 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims 1
- 102000011117 Transforming Growth Factor beta2 Human genes 0.000 claims 1
- 108010009583 Transforming Growth Factors Proteins 0.000 claims 1
- 102000009618 Transforming Growth Factors Human genes 0.000 claims 1
- 101800000304 Transforming growth factor beta-2 Proteins 0.000 claims 1
- 102000056172 Transforming growth factor beta-3 Human genes 0.000 claims 1
- 108090000097 Transforming growth factor beta-3 Proteins 0.000 claims 1
- 102000044159 Ubiquitin Human genes 0.000 claims 1
- 108090000848 Ubiquitin Proteins 0.000 claims 1
- 108010073923 Vascular Endothelial Growth Factor C Proteins 0.000 claims 1
- 102100038232 Vascular endothelial growth factor C Human genes 0.000 claims 1
- 101150109862 WNT-5A gene Proteins 0.000 claims 1
- 102000043366 Wnt-5a Human genes 0.000 claims 1
- 108700020483 Wnt-5a Proteins 0.000 claims 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims 1
- 229950006323 angiotensin ii Drugs 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 210000001367 artery Anatomy 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 239000002975 chemoattractant Substances 0.000 claims 1
- 210000002744 extracellular matrix Anatomy 0.000 claims 1
- 230000002518 glial effect Effects 0.000 claims 1
- 229960002897 heparin Drugs 0.000 claims 1
- 229920000669 heparin Polymers 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 102000028416 insulin-like growth factor binding Human genes 0.000 claims 1
- 108091022911 insulin-like growth factor binding Proteins 0.000 claims 1
- 229940096397 interleukin-8 Drugs 0.000 claims 1
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 claims 1
- 239000002523 lectin Substances 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 210000000265 leukocyte Anatomy 0.000 claims 1
- 210000003712 lysosome Anatomy 0.000 claims 1
- 230000001868 lysosomic effect Effects 0.000 claims 1
- 239000000186 progesterone Substances 0.000 claims 1
- 229960003387 progesterone Drugs 0.000 claims 1
- 229930002330 retinoic acid Natural products 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 229960001727 tretinoin Drugs 0.000 claims 1
- 210000003462 vein Anatomy 0.000 claims 1
- 102000004858 Growth differentiation factor-9 Human genes 0.000 abstract 2
- 108090001086 Growth differentiation factor-9 Proteins 0.000 abstract 2
- 102100021866 Hepatocyte growth factor Human genes 0.000 abstract 2
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract 2
- 102000014429 Insulin-like growth factor Human genes 0.000 abstract 2
- 102000015336 Nerve Growth Factor Human genes 0.000 abstract 2
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 230000002281 colonystimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/529—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1. Фармацевтическая композиция для человека или животного (В) для стимулирования стволовых клеток, которая содержит по меньшей мере два агента, стимулирующие стволовые клетки, и по меньшей мере одно фармацевтически приемлемое вспомогательное вещество, при этом указанные по меньшей мере два агента, стимулирующие стволовые клетки, выбраны из группы, включающей TGFβ-1, BMP-4, FGF-2, IGF-1, активин-A, кардиотропин 1, кардиогенол С и их смеси.2. Фармацевтическая композиция по п.1, в которой указанные по меньшей мере два агента, стимулирующих стволовые клетки, представляют собой TGFβ-1, BMP-4, FGF-2, IGF-1, активин-A, кардиотропин 1 и кардиогенол С.3. Фармацевтическая композиция по п.1, отличающаяся тем, что указанная композиция дополнительно содержит ингибитор тромбина.4. Фармацевтическая композиция по п.1, отличающаяся тем, что указанная композиция дополнительно содержит по меньшей мере одно вещество, выбранное из группы, включающей факторы роста, цитокины, гормоны и их сочетания.5. Фармацевтическая композиция по п.4, в которой по меньшей мере одно указанное вещество выбирают из группы, включающей:- костный морфогенетический белок (BMP), такой как BMP-1, BMP-2, BMP-5, BMP-6- эпидермальный фактор роста (EGF);- эритропоэтин (ЕРО);- фактор роста фибробластов (FGF), такой как FGF-1, FGF-4, FGF-5, FGF-12, FGF-13, FGF-15, FGF-20;- колониестимулирующий фактор гранулоцитов (G-CSF);- колониестимулирующий фактор гранулоцитов и макрофагов (GM-CSF);- ростовой фактор дифференцировки-9 (GDF-9);- фактор роста гепатоцитов (HGF);- инсулиноподобный фактор роста (IGF), такой как IGF-2;- миостатин (GDF-8);- нейротрофин, такой как NT-3, NT-4, NT-1 и фактор роста нервов (NGF);- тромбоцитарный фактор роста (PDGF), такой как PDGF-бета, PDGF-AA, PDGF-BB;- тромб�1. A pharmaceutical composition for a human or animal (B) for stimulating stem cells, which contains at least two agents that stimulate stem cells, and at least one pharmaceutically acceptable excipient, with at least two agents that stimulate stem cells are selected from the group consisting of TGFβ-1, BMP-4, FGF-2, IGF-1, activin-A, cardiotropin 1, cardiogenol C, and mixtures thereof. 2. The pharmaceutical composition according to claim 1, wherein said at least two stem cell stimulating agents are TGFβ-1, BMP-4, FGF-2, IGF-1, activin-A, cardiotropin 1 and cardiogenol C.3. The pharmaceutical composition according to claim 1, characterized in that said composition further comprises a thrombin inhibitor. The pharmaceutical composition according to claim 1, characterized in that said composition further comprises at least one substance selected from the group comprising growth factors, cytokines, hormones, and combinations thereof. The pharmaceutical composition according to claim 4, in which at least one of the specified substance is selected from the group including: - bone morphogenetic protein (BMP), such as BMP-1, BMP-2, BMP-5, BMP-6 - epidermal growth factor (EGF); - erythropoietin (EPO); - fibroblast growth factor (FGF), such as FGF-1, FGF-4, FGF-5, FGF-12, FGF-13, FGF-15, FGF-20; - colony stimulating granulocyte factor (G-CSF); - colony-stimulating factor of granulocytes and macrophages (GM-CSF); - growth differentiation factor-9 (GDF-9); - hepatocyte growth factor (HGF); - insulin-like growth factor (IGF), such as IGF-2; - myostatin (GDF-8) ; - neurotrophin, such as NT-3, NT-4, NT-1 and nerve growth factor (NGF); - platelet growth factor (PDGF), such as PDGF-beta, PDGF-AA, PDGF-BB; - thrombus
Claims (33)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EPPCT/EP2009/066251 | 2009-12-02 | ||
EP2009066251 | 2009-12-02 | ||
PCT/EP2010/068700 WO2011067317A1 (en) | 2009-12-02 | 2010-12-02 | Pharmaceutical compositions for the stimulation of stem cells. |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2012120834A true RU2012120834A (en) | 2014-01-20 |
Family
ID=42316097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2012120834/15A RU2012120834A (en) | 2009-12-02 | 2010-12-02 | PHARMACEUTICAL COMPOSITIONS FOR STIMULATION OF STEM CELLS |
Country Status (12)
Country | Link |
---|---|
JP (1) | JP2013512877A (en) |
KR (1) | KR20120099751A (en) |
CN (1) | CN102711798A (en) |
AU (1) | AU2010326633A1 (en) |
BR (1) | BR112012013164A2 (en) |
CA (1) | CA2781493A1 (en) |
IL (1) | IL219901A0 (en) |
MX (1) | MX2012005976A (en) |
NZ (1) | NZ599930A (en) |
RU (1) | RU2012120834A (en) |
TW (1) | TW201141510A (en) |
WO (1) | WO2011067317A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016006885A1 (en) * | 2014-07-07 | 2016-01-14 | 메디포스트(주) | Hair growth-promoting function of culture medium of stimulated stem cells and use thereof |
CN105079791A (en) * | 2015-09-18 | 2015-11-25 | 郑榆坤 | Composition for stimulating endogenous stem cells in vivo and application of composition |
RU2634576C1 (en) * | 2016-10-24 | 2017-10-31 | Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) | Method for tissue regeneration stimulation |
CN107050428B (en) * | 2017-03-23 | 2020-05-05 | 温州医科大学 | FGF20 medicament and application thereof in treatment of cerebral trauma |
CN107648592B (en) * | 2017-11-13 | 2021-05-14 | 深圳市喆邦生物工程有限公司 | Application of chemokine CCL4 in preparation of medicine for treating bone fracture |
RU2686718C1 (en) * | 2018-03-12 | 2019-04-30 | Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) | Agent stimulating mesenchymal progenitor cell functions in vitro |
KR102106710B1 (en) | 2018-10-11 | 2020-05-04 | 강원대학교산학협력단 | hematopoietic differentiation of human pluripotent stem cells in a developmental stage-specific manner |
CN111195350A (en) * | 2020-01-15 | 2020-05-26 | 重庆大学 | Application of combination of IGF1 and IGF1Ec24 in preparation of medicines for promoting tissue repair and regeneration |
US20240058389A1 (en) * | 2020-03-17 | 2024-02-22 | Hierabio Inc. | Composition for preventing or treating ischemic diseases, comprising cardiac stem cells |
CN111621525B (en) * | 2020-06-18 | 2021-04-23 | 中赛干细胞基因工程有限公司 | Application of STX1B gene in promoting growth and differentiation of human adipose-derived mesenchymal stem cells |
CN116836920B (en) * | 2023-08-21 | 2024-05-24 | 广东横琴粤澳深度合作区齐美国际干细胞医院有限公司 | Serum-free culture medium and method for preparing mesenchymal stem cells by using same |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8173118B2 (en) * | 2004-07-30 | 2012-05-08 | Mayo Foundation For Medical Education And Research | Compositions consisting essentially of TGF-β, BMP-2 FGF-4, leukemia inhibitory factor, IGF-1, IL-6 and H-α-thrombin |
ATE481978T1 (en) * | 2005-01-25 | 2010-10-15 | Five Prime Therapeutics Inc | COMPOSITIONS AND METHODS FOR TREATING HEART DISEASES |
US9765298B2 (en) * | 2006-07-24 | 2017-09-19 | Mayo Foundation For Medical Education And Research | Methods and materials for providing cardiac cells |
US8481075B2 (en) * | 2007-12-13 | 2013-07-09 | Beijing Shengyiyao Science & Technology Development Co. Ltd. | Preparation and application of biodegradable-material-made microsphere vascular embolus containing liposome-encapsulated cytokines |
-
2010
- 2010-12-02 RU RU2012120834/15A patent/RU2012120834A/en not_active Application Discontinuation
- 2010-12-02 BR BR112012013164A patent/BR112012013164A2/en not_active IP Right Cessation
- 2010-12-02 WO PCT/EP2010/068700 patent/WO2011067317A1/en active Application Filing
- 2010-12-02 NZ NZ599930A patent/NZ599930A/en not_active IP Right Cessation
- 2010-12-02 TW TW099141986A patent/TW201141510A/en unknown
- 2010-12-02 AU AU2010326633A patent/AU2010326633A1/en not_active Abandoned
- 2010-12-02 JP JP2012541498A patent/JP2013512877A/en not_active Withdrawn
- 2010-12-02 CN CN201080053800XA patent/CN102711798A/en active Pending
- 2010-12-02 CA CA2781493A patent/CA2781493A1/en not_active Abandoned
- 2010-12-02 MX MX2012005976A patent/MX2012005976A/en unknown
- 2010-12-02 KR KR1020127017238A patent/KR20120099751A/en not_active Application Discontinuation
-
2012
- 2012-05-20 IL IL219901A patent/IL219901A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
KR20120099751A (en) | 2012-09-11 |
CN102711798A (en) | 2012-10-03 |
BR112012013164A2 (en) | 2016-03-01 |
AU2010326633A1 (en) | 2012-05-31 |
TW201141510A (en) | 2011-12-01 |
NZ599930A (en) | 2014-04-30 |
JP2013512877A (en) | 2013-04-18 |
IL219901A0 (en) | 2012-07-31 |
CA2781493A1 (en) | 2011-06-09 |
MX2012005976A (en) | 2012-06-25 |
WO2011067317A1 (en) | 2011-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2012120834A (en) | PHARMACEUTICAL COMPOSITIONS FOR STIMULATION OF STEM CELLS | |
EP2506867B1 (en) | Pharmaceutical compositions for the stimulation of stem cells. | |
JP2013512877A5 (en) | ||
Hofer et al. | Brain-derived neurotrophic factor prevents neuronal death in vivo | |
Ensoli et al. | Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS. | |
Hughes et al. | Members of several gene families influence survival of rat motoneurons in vitro and in vivo | |
Ip et al. | Injury‐induced regulation of ciliary neurotrophic factor mRNA in the adult rat brain | |
Ten Dijke et al. | Growth factors for wound healing | |
Schultz et al. | Neovascular growth factors | |
RU2007146986A (en) | METHODS FOR TREATING TUMORS OF THE BRAIN WITH USE OF ANTIBODIES | |
Westermann et al. | Basic fibroblast growth factor (bFGF), a multifunctional growth factor for neuroectodermal cells | |
Li et al. | Protective mechanism and treatment of neurogenesis in cerebral ischemia | |
WO2002094872A1 (en) | Therapeutic uses of keratinocyte growth factor-2 | |
WO1997045127A1 (en) | Uridine-comprising therapeutic active agent for treatment of neurodegenerative disorders | |
US20040138128A1 (en) | Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors | |
AU2001258322B2 (en) | Formulation having mobilising activity | |
Bulgin | Therapeutic angiogenesis in ischemic tissues by growth factors and bone marrow mononuclear cells administration: biological foundation and clinical prospects | |
AU2001258322A1 (en) | Formulation having mobilising activity | |
US6764683B1 (en) | Loop peptide and TGFα for stimulating stem cell proliferation and migration | |
de Haan et al. | Prophylactic pretreatment of mice with hematopoietic growth factors induces expansion of primitive cell compartments and results in protection against 5-fluorouracil-induced toxicity | |
Hefti et al. | Growth factors and Alzheimer’s disease | |
Ferrari et al. | Basic fibroblast growth factor affects the survival and development of mesencephalic neurons in culture | |
CA2255748C (en) | Uridine-comprising therapeutic active agent for treatment of neurodegenerative disorders | |
Hill et al. | Class 1 heparin binding growth factor promotes the differentiation but not the survival of ciliary neurones in vivo | |
Finklestein | Growth factors in stroke |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20150625 |